ArticleEndocrine2016

Docetaxel plus androgen deprivation withdrawal may restore sensitivity to luteinizing hormone-releasing hormone analog therapy in castration-resistant prostate cancer patients.

Francesca Bedussi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.